10x Science Has Raised A $4.8 Million Seed Round To Help Pharmaceutical Researchers Understand Complex Molecules.
AI drug discovery is accelerating fast—10x Science aims to solve the biggest bottleneck in turning predictions into real treatments.
Matilda
10x Science Has Raised A $4.8 Million Seed Round To Help Pharmaceutical Researchers Understand Complex Molecules.
AI drug discovery is advancing at an unprecedented pace, generating thousands of potential treatments in record time. But a critical challenge remains: how do scientists determine which of these AI-generated drug candidates actually work? A new startup, 10x Science, is stepping in to solve this problem by transforming how researchers analyze and validate complex molecules. Backed by fresh funding and deep scientific expertise, the company is tackling one of the biggest bottlenecks in modern biotechnology. AI Drug Discovery Is Moving Faster Than Science Can Handle The rise of artificial intelligence in biology—especially breakthroughs led by Google DeepMind—has fundamentally changed how scientists approach drug discovery. AI systems can now predict protein structures, simulate molecular interactions, and generate vast numbers of potential therapeutic candidates. However, this rapid innovation has created a new problem. While AI can generate ideas quickly, verifying those ideas in the real…
